ArticleClinical cancer research : an official journal of the American Association for Cancer Research2011

Killing of chronic lymphocytic leukemia by the combination of fludarabine and oxaliplatin is dependent on the activity of XPF endonuclease.

Alma Zecevic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.